Matthew Castelo

Dr. Matthew Castelo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMatthew Castelo
Matthew Castelo
CSColin Sue-Chue-Lam
Colin Sue-Chue-Lam
LPLawrence Paszat
Lawrence Paszat
TKTeruko Kishibe
Teruko Kishibe
ASAdena S. Scheer
Adena S. Scheer
Nancy Noel BaxterNancy Noel Baxter
Nancy Noel Baxter
Background: The incidence of colorectal cancer is rising in adults <50 years of age. As a primarily unscreened population, they may have clinically important delays to diagnosis and treatment. This study aimed to review the literature on delay intervals in patients <50 years with colorectal cancer (CRC), and explore associations between longer intervals and outcomes. Methods: MEDLINE, Embase, and LILACS were searched until December 2, 2021. We included studies published after 1990 reporting any delay interval in adults <50 with CRC. Interval measures and associations with stage at presentation or survival were synthesized and described in a narrative fashion. Risk of bias was assessed using the Newcastle-Ottawa Scale, Institute of Health Economics Case Series Quality Appraisal Checklist, and the Aarhus Checklist for cancer delay studies. Results: 55 studies representing 188,530 younger CRC patients were included. Most studies used primary data collection (64%), and 47% reported a single center. Sixteen unique intervals were measured. The most common interval was symptom onset to diagnosis (21 studies; N = 2,107). By sample size, diagnosis to treatment start was the most reported interval (12 studies; N = 170,463). Four studies examined symptoms onset to treatment start (total interval). The shortest was a mean of 99.5 days and the longest was a median of 217 days. There was substantial heterogeneity in the measurement of intervals, and quality of reporting. Higher-quality studies were more likely to use cancer registries, and be population-based. In four studies reporting the relationship between intervals and cancer stage or survival, there were no clear associations between longer intervals and adverse outcomes. Discussion: Adults <50 with CRC may have intervals between symptom onset to treatment start greater than 6 months. Studies reporting intervals among younger patients are limited by inconsistent results and heterogeneous reporting. There is insufficient evidence to determine if longer intervals are associated with advanced stage or worse survival. Other: This study’s protocol was registered with the Prospective Register of Systematic Reviews (PROSPERO; registration number CRD42020179707).

7 May 2020 in BJS Open
Verified
Journal Article
Open access
PDF file
MCMatthew Castelo
Matthew Castelo
CSC. Sue‐Chue‐Lam
C. Sue‐Chue‐Lam
TKT. Kishibe
T. Kishibe
SAS A Acuna
S A Acuna
Nancy Noel BaxterNancy Noel Baxter
Nancy Noel Baxter
Background Urinary catheters are placed after rectal surgery to prevent urinary retention, but prolonged use may increase the risk of urinary tract infection (UTI). This review evaluated the non‐inferiority of early urinary catheter removal compared with late removal for acute urinary retention risk after rectal surgery. Methods MEDLINE, Embase and the Cochrane Central Register of Controlled Trials were searched from January 1980 to February 2019. RCTs comparing early versus late catheter removal after rectal surgery were eligible. Primary outcomes were acute urinary retention and UTI; the secondary outcome was length of hospital stay. Early catheter removal was defined as removal up to 2 days after surgery, with late removal after postoperative day 2. The non‐inferiority margin from an included trial was used for analysis of change in urinary retention (ΔNI = 15 per cent). Pooled estimates of risk differences (RDs) were derived from random‐effects models. Risk of bias was assessed using a modified Cochrane risk‐of‐bias tool. Results Four trials were included, consisting of 409 patients. There was insufficient evidence to conclude non‐inferiority of early versus late catheter removal for acute urinary retention (RD 9 (90 per cent c.i. −1 to 19) per cent; PNI = 0·31). Early catheter removal was superior for UTI (RD −11 (95 per cent c.i. −17 to −4) per cent; P = 0·001). Results for length of stay were mixed. There were insufficient data to conduct subgroup analyses. Conclusion The existing literature is inconclusive for non‐inferiority of early versus late urinary catheter removal for acute urinary retention. Early catheter removal is superior in terms of reducing the risk of UTI.

12 November 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
MCMatthew Castelo
Matthew Castelo
CSColin Sue-Chue-Lam
Colin Sue-Chue-Lam
Lawrence Frank PaszatLawrence Frank Paszat
Lawrence Frank Paszat
ASAdena S. Scheer
Adena S. Scheer
BHBettina Hansen
Bettina Hansen
Nancy Noel BaxterNancy Noel Baxter
Nancy Noel Baxter
Outcome disparities between adults <50 with colorectal cancer (CRC) and older adults may be explained by clinical delays. This study synthesized the literature comparing delays and outcomes between younger and older adults with CRC. Databases were searched until December 2021. We included studies published after 1990 reporting delay in adults <50 that made comparisons to older adults. Comparisons were described narratively and stage between age groups was meta-analyzed. 39 studies were included representing 185,710 younger CRC patients and 1,422,062 older patients. Sixteen delay intervals were compared. Fourteen studies (36%) found significantly longer delays among younger adults, and nine (23%) found shorter delays among younger patients. Twelve studies compared time from symptom onset to diagnosis (N younger = 1538). Five showed significantly longer delays for younger adults. Adults <50 years also had higher odds of advanced stage (16 studies, pooled OR for Stage III/IV 1.76, 95% CI 1.52–2.03). Ten studies compared time from diagnosis to treatment (N younger = 171,726) with 4 showing significantly shorter delays for younger adults. All studies showing longer delays for younger adults examined pre-diagnostic intervals. Three studies compared the impact of delay on younger versus older adult. One showed longer delays were associated with advanced stage and worse survival in younger but not older adults. Longer delays among younger adults with CRC occur in pre-diagnostic intervals.

20 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
FAFernando A. Angarita
Fernando A. Angarita
RBRobert Brumer
Robert Brumer
MCMatthew Castelo
Matthew Castelo
NENestor F. Esnaola
Nestor F. Esnaola
SEStephen B. Edge
Stephen B. Edge
Kazuaki TakabeKazuaki Takabe
Kazuaki Takabe
It is necessary to identify appropriate areas of de-escalation in breast cancer treatment to minimize morbidity and maximize patients’ quality of life. Less radical treatment modalities, or even no treatment, have been reconsidered if they offer the same oncologic outcomes as standard therapies. Identifying which patients benefit from de-escalation requires particular care, as standard therapies will continue to offer adequate cancer outcomes. We provide an overview of the literature on the de-escalation of treatment of ductal carcinoma in situ (DCIS), local treatment of breast cancer, and surgery after neoadjuvant systemic therapy. De-escalation of breast cancer treatment is a key area of investigation that will continue to remain a priority. Improvements in understanding the natural history and biology of breast cancer, imaging modalities, and adjuvant treatments will expand this even further. Future efforts will continue to challenge us to consider the true role of various treatment modalities.

24 February 2023 in Gastroenterology
Verified
Journal Article
Open access
MCMatthew Castelo
Matthew Castelo
LPLawrence Paszat
Lawrence Paszat
BHBettina E. Hansen
Bettina E. Hansen
ASAdena S. Scheer
Adena S. Scheer
NFNeil Faught
Neil Faught
Nancy Noel BaxterNancy Noel Baxter
Nancy Noel Baxter
Younger adults (aged <50 years) with colorectal cancer (CRC) may have prolonged delays to diagnosis and treatment that are associated with adverse outcomes. We compared delay intervals by age for patients with CRC in a large population. This was a population-based study of adults diagnosed with CRC in Ontario, Canada, from 2003 to 2018. We measured the time between presentation and diagnosis (diagnostic interval), diagnosis and treatment start (treatment interval), and the time from presentation to treatment (overall interval). We compared interval lengths between adults aged <50 years, 50 to 74 years, and 75 to 89 years using multivariable quantile regression. Included were 90,225 patients with CRC. Of these, 6853 patients (7.6%) were aged <50 years. Younger patients were more likely to be women, present emergently, have stage IV disease, and have rectal cancer compared with middle-aged patients. Factors associated with significantly longer overall intervals included female sex (8.7 days; 95% confidence interval [CI], 6.6-10.9 days) and rectal cancer compared with proximal colon cancer (9.8 days; 95% CI, 7.4-2.2 days). After adjustment, adults aged 75 years had longer overall intervals. Younger adults present more often with stage IV CRC but have overall similar times from presentation to treatment as screening-eligible older adults.

12 October 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
FAFernando A. Angarita
Fernando A. Angarita
BPBenjamin Price
Benjamin Price
MCMatthew Castelo
Matthew Castelo
MTMauricio Tawil
Mauricio Tawil
JAJuan Carlos Ayala
Juan Carlos Ayala
LTLilian Torregrossa
Lilian Torregrossa